🟢 20/20 Biolabs is trading 10.3% up today as investors rotate into high-risk small caps

20/20 Biolabs is trading 10.3% up at $0.47 as investors rotate into higher-risk small-cap names amid improving risk appetite.

• The move aligns with a broader U.S. equity rally, with major indexes gaining more than 1%.
• Positive macro data and easing geopolitical tensions are supporting a risk-on environment.
• The price action appears driven by market sentiment rather than any new company-specific catalysts.